A new therapeutic candidate for breast cancer: laminin-332 overexpressing myofibroblast formation via epithelial-mesenchymal transition in the interface zone

被引：0
|
作者：
Kim, Baek Gil [1 ]
Kang, Suki [1 ]
Cho, Nam Hoon [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2011年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：207 / 208
页数：2
相关论文
共 50 条
  • [41] GP5 regulates epithelial-mesenchymal transition in breast cancer via the PI3K/AKT signaling pathway
    Kui Xiang
    Hua Yanshan
    Zhao Chunmei
    Guo Minmin
    Wang Yan
    Yi Xiaojia
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (17) : 1501 - 1517
  • [42] Determining Factors in the Therapeutic Success of Checkpoint Immunotherapies against PD-L1 in Breast Cancer: A Focus on Epithelial-Mesenchymal Transition Activation
    Segovia-Mendoza, Mariana
    Romero-Garcia, Susana
    Lemini, Cristina
    Prado-Garcia, Heriberto
    JOURNAL OF IMMUNOLOGY RESEARCH, 2021, 2021
  • [43] Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models
    Go, Ryeo-Eun
    Kim, Cho-Won
    Jeon, So-Ye
    Byun, Yong-Sub
    Jeung, Eui-Bae
    Nam, Ki-Hoan
    Choi, Kyung-Chul
    ENVIRONMENTAL TOXICOLOGY, 2017, 32 (04) : 1439 - 1454
  • [44] Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells
    Galarza, Tamara E.
    Delgado, Monica A. Taquez
    Mohamad, Nora A.
    Martin, Gabriela A.
    Cricco, Graciela P.
    BIOCHEMICAL PHARMACOLOGY, 2020, 180
  • [45] Inhibitory effect of melatonin on hypoxia-induced vasculogenic mimicry via suppressing epithelial-mesenchymal transition (EMT) in breast cancer stem cells
    Maroufi, Nazila Fathi
    Amiri, Maryam
    Dizaji, Babak Faraji
    Vahedian, Vahid
    Akbarzadeh, Maryam
    Roshanravan, Neda
    Haiaty, Sanya
    Nouri, Mohammad
    Rashidi, Mohammad-Reza
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 881
  • [46] DNASE1L2, as a Carcinogenic Marker, Affects the Phenotype of Breast Cancer Cells Via Regulating Epithelial-Mesenchymal Transition Process
    Liu, Chang-Rui
    Meng, Fan-Hua
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2021, 36 (02) : 180 - 188
  • [47] Epithelial-mesenchymal transition sensitizes breast cancer cells to paraptosis-mediated cell death via the fungus-derived sesterpenoid, Ophiobolin A
    Reisenauer, K.
    Tao, Y.
    Ingros, A.
    Philip, T.
    Evidente, A.
    Kornienko, A.
    Romo, D.
    Taube, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [48] GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7
    Zhou, Tian
    Yu, Lei
    Huang, Jianjun
    Zhao, Xueke
    Li, Yanwen
    Hu, Yaxin
    Lei, Yu
    AGING-US, 2019, 11 (10): : 3298 - 3314
  • [49] Nalbuphine suppresses breast cancer stem-like properties and epithelial-mesenchymal transition via the AKT-NFκB signaling pathway
    Jiachuan Yu
    Yuanyuan Luo
    Qingping Wen
    Journal of Experimental & Clinical Cancer Research, 38
  • [50] CUL1 Knockdown Attenuates the Adhesion, Invasion, and Migration of Triple-Negative Breast Cancer Cells via Inhibition of Epithelial-Mesenchymal Transition
    Ren, Ze-Qiang
    Yan, Wen-Jing
    Zhang, Xiu-Zhong
    Zhang, Peng-Bo
    Zhang, Chong
    Chen, Shou-Kun
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 1153 - 1163
12345